Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 65 for “"HER3"”.
-
ENGINEERED MULTIVALENCY FOR ENHANCED AFFIBODY-BASED HER3 CANCER THERAPY
The receptor tyrosine kinase HER3 is well established as a compelling therapeutic target in numerous cancers, including ovarian cancer. HER3 potently activates the PI3K/Akt pro-survival pathway, mediates drug resistance, and is implicated in cancer progression and poor clinical outcomes. Yet, …
-
Investigating a role of HER3 in anti-HER2 target therapy in breast cancer
… and acquired resistance is a common problem. HER3 has been shown to be a key candidate in mediating resistance to trastuzumab and other ErbB inhibitors. The aims of the project are to investigate the resistance mechanisms and the relevant biomarkers in relation to trastuzumab treatment and …
-
HER3, CK5/6 und APOBEC3B als Biomarker in histologisch definierten Subtypen des Ovarialkarzinoms
… Ansätzen profitieren können. Deshalb haben wir HER3, CK5/6 und APOBEC3B als Biomarker in verschiedenen histologischen Ovarialkarzinomsubtypen, vor allem im high-grade serösen Karzinom (HGSC), dem häufigsten Subtyp, untersucht. Methodik Mittels Immunhistochemie wurde die Expression von HER3, …
-
Heregulin Activates a Novel HER2/HER3-MTK1-GIT1/ERK1/2 MAPK Signaling Pathway
… human epidermal growth factor receptor 2/3 (HER2/HER3)-heregulin beta1 (HRG) induced extracellular acidification and cell migration in MCF-7 breast cancer cells. Furthermore, it was shown that HRG stimulation leads to association of MTK1 with tyrosine phosphorylated HER3 in MCF-7 and T-47D breast …
-
Ανοσοϊστοχημική και μοριακή μελέτη των δεικτών pten, topoisomerase iiα και her3 στο καρκίνωμα του λάρυγγα, με τη μέθοδο των ιστικών μικροσυστοιχιών
… aim of this thesis was to study the molecules HER3, PTEN and TopoIIa at the protein level by immunohistochemistry (IHC) method and at DNA level with fluorescent in situ hybridization (FISH) and to explore the possible prognostic significance. This study analyzed tumors from 122 patients with …
-
The role of ERBB3 inhibitors as cancers therapeutics
… tyrosine kinases namely, EGFR/ErbB1, HER2/ErbB2, HER3/ErbB3 and HER4/ErbB4. The ErbB family of receptors plays a major role in morphogenesis of the human body as well as various cellular responses such as cell growth, differentiation and proliferation. Overexpression and dysregulation of these …
-
The effects of dimer and oligomer separation on cell signaling in the EGFR family
… kinases (RTKs) includes EGFR, HER2/ErbB2, HER3/ErbB3, and HER4/ErbB. The EGFR family members play crucial roles in development and in regulating normal cellular processes. However, these receptors are found to be overexpressed or mutated in various cancers. The complete mechanism by which …
-
Identifikation signaltransduktionsrelevanter Gene in Melanom-zelllinien durch Entwicklung und Anwendung eines Verfahrens zur Analyse von Daten aus cDNA-Hybridisierungsarrays
… wurde gefunden, dass bei ADAM-9, ADAM-10, HER3, FAK, SHC und dem IGF-1-Rezeptor die Unterschiede der Expression zwischen Melanomzelllinien und Melanozyten besonders ausgeprägt waren. Bei weiteren Genen wurden schwächer ausgeprägte, jedoch ebenfalls interessante Expressionsmuster beobachtet. …
-
An optical proteomic profile of the HER2 family in breast tumours and the effect of exposure to tyrosine kinase inhibitors
… inevitably develops to both drugs. HER2:HER3 dimerisation is vital to the translation of extracellular signals, via intracellular signaling cascades, to promote cancer cell proliferation, invasion and metastasis, and is studied herein. Regulation of the amplitude and kinetics of signal …
-
Engineering Anti-HER2 Antibodies for Enhanced Therapeutic Potency
… treatment through ligand-mediated HER2/HER3 signaling. The first study addresses this issue by engineering a bispecific antibody targeting HER2 and HER3. A combination of immunoblots and proliferation assays were used to characterize the interaction between HER2, HER3, and the bispecific …
-
Multiscale Modeling of the ErbB Receptor Tyrosine Kinase Signaling Network Through Theory and Experiment
… or mutated in human cancers, with a focus on the HER3 and HER4 kinases. Our multiscale model of HER3, a kinase which, until recently, has been considered kinase-dead, presents evidence of HER3 catalytic activity and demonstrates that even a weak HER3 signal can be amplified by other cellular …
-
Expression von EGF- Rezeptoren in Plazentazotten von normalem Plazentagewebe und von Frauen mit hypertensiven Erkrankungen in der Schwangerschaft
… vier Rezeptoren der EGF-Familie (HER1, HER2, HER3 und HER4) werden sowohl von gesunden Schwangeren als auch von Frauen mit hypertensiven Erkrankungen in der Schwangerschaft in villoesen Trophoblasten exprimiert. Die Kernfaerbungen von HER1, HER2 und HER3 waren fuer Synzytiotrophoblasten und …
-
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
… upon SATB1 knockdown. The transcription of HER3 and its ligands Heregulin α & β was attenuated in all the seven primary cell lines, irrespectively of the growth inhibitory effects of SATB1 knockdown. These results demonstrated the role of SATB1 in the process of EMT and in autocrine …
-
Expressionsmuster und prognostische Relevanz der menschlichen Wachstumsfaktorrezeptoren (HER) in Plattenepithelkarzinomen der Zervix
… Growthfactor Rezeptoren (EGFR=HER1, HER2, HER3 und HER4) untersucht. Die Nachweise erfolgten mittels Immunhistochemie. Die Amplifikation des HER2-Gens wurde mit der Fluoreszenz in situ Hybridisierung (FISH) geprüft. Die Patientinnen wurden zwischen 1987 und 1994 behandelt. Der …
-
Agents for Hepatocellular Carcinoma: Synthesis and Mode of Action
… It inhibited the phosphorylation of FGFR4 and HER3 in HuH7 cells at low concentrations. Inhibition of FGFR4 and HER3 may contribute to the growth inhibitory effects of 3-12 on HuH7 cells.Several members of the library inhibited Sirt 2 activity. The most potent inhibitors were the …
-
Herceptin resistance in HER2-moderately expressed breast cancer
… an inability of Herceptin to maintain decreased HER3 and AKT activation in a subset of HER2-negative breast cancer cell lines (those that are HER2 2+, or HER2-moderately expressed) is responsible for reduced response. Surprisingly HER3 activation may also have a role in propagating the effects of …
-
Prognostic biomarkers in upper gastrointestinal adenocarcinoma
… of EGFR (Epidermal Growth Factor Receptor 1) and HER3 in tissue from the first cohort was also examined. EGFR was independently associated with a shorter overall survival. High HER3 expression was associated with a longer overall survival, although not independently. The expression, …
-
Developing Affimers for the detection of biomarkers in cancer
… membrane target molecules, EGFR, HER2, and HER3 were used as models to optimise the process of Affimers isolation and selection using phage display technology. In vitro production of Affimers using bacterial cells was assessed and optimised. Following optimisation, a range of Affimers that …
-
Η έκφραση των υποδοχέων της τάξης HER στον καρκίνο του μαστού και βιολογική συμπεριφορά των καρκινικών κυττάρων
… cycle. We found a positive correlation between HER3 and HER4 mRNA levels. Compared to normal breast tissue, all four receptors were overexpressed in breast tumors and the strongest overexpression was found at HER3. Compared to normal breast tissue p21Δ, the 19kDa degraded form of p21 protein, …
Page 1 of 4